Specific red cell adherence test applied to tumors of ureter and renal pelvis

M. B. Gruber; S. N. Becker; M. M. Warren; M. J. Rambo; C. P. Davis

doi:10.1016/0090-4295(82)90189-3

Specific red cell adherence test applied to tumors of ureter and renal pelvis

M. B. Gruber, S. N. Becker, M. M. Warren, M. J. Rambo, C. P. Davis

Research output: Contribution to journal › Article

1 Scopus citations

Abstract

The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.

Original language	English (US)
Pages (from-to)	361-365
Number of pages	5
Journal	Urology
Volume	19
Issue number	4
DOIs	https://doi.org/10.1016/0090-4295(82)90189-3
State	Published - Apr 1982

Fingerprint

ASJC Scopus subject areas

Urology

Cite this

Gruber, M. B., Becker, S. N., Warren, M. M., Rambo, M. J., & Davis, C. P. (1982). Specific red cell adherence test applied to tumors of ureter and renal pelvis. Urology, 19(4), 361-365. https://doi.org/10.1016/0090-4295(82)90189-3

@article{fb49219d9c884e15a392bfb2aa1e52ee,

title = "Specific red cell adherence test applied to tumors of ureter and renal pelvis",

abstract = "The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.",

author = "Gruber, {M. B.} and Becker, {S. N.} and Warren, {M. M.} and Rambo, {M. J.} and Davis, {C. P.}",

year = "1982",

month = apr

doi = "10.1016/0090-4295(82)90189-3",

language = "English (US)",

volume = "19",

pages = "361--365",

journal = "Urology",

issn = "0090-4295",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Specific red cell adherence test applied to tumors of ureter and renal pelvis

AU - Gruber, M. B.

AU - Becker, S. N.

AU - Warren, M. M.

AU - Rambo, M. J.

AU - Davis, C. P.

PY - 1982/4

Y1 - 1982/4

N2 - The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.

AB - The specific red cell adherence (SRCA) test used previously as a prognostic indicator of bladder tumors was used in a retrospective review of 14 patients with transitional cell carcinoma of the ureter and renal pelvis. SRCA-positive individuals appear to have better survival and progress less frequently to metastatic disease. Of five patients with positive reactions, none had distant metastases. Conversely, in SRCA-negative individuals metastatic disease developed more frequently (4 of 9). The SRCA test can be as useful a test of the prognosis of ureteral and renal pelvis tumors as it is of urinary bladder tumors.

UR - http://www.scopus.com/inward/record.url?scp=0020070243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020070243&partnerID=8YFLogxK

U2 - 10.1016/0090-4295(82)90189-3

DO - 10.1016/0090-4295(82)90189-3

M3 - Article

C2 - 7072026

AN - SCOPUS:0020070243

VL - 19

SP - 361

EP - 365

JO - Urology

JF - Urology

SN - 0090-4295

IS - 4

ER -

Access to Document

10.1016/0090-4295(82)90189-3